Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1651 1657
This examiner grants 44% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17159870 | FUNGAL SPECIES, COMPOSITIONS DERIVED THEREFROM, AND USES THEREOF | Non-Final OA | President and Fellows of Harvard College |
| 17617285 | SYSTEMS COMPRISING SUBSTRATES AND METHODS OF USING THE SAME FOR DETECTION OF PANCREATIC CANCERS | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17607718 | INDUSTRIAL FERMENTATION PROCESS FOR MICROBIAL CELLS USING A FED-BATCH PRE-CULTURE | Non-Final OA | BASF SE |
| 17640262 | ENZYME COMPOSITION | Non-Final OA | DSM IP ASSETS B.V. |
| 18441878 | E3 UBIQUITIN LIGASE (UBE3A) PROTEIN TARGETS | Non-Final OA | Hoffmann-La Roche Inc. |
| 17796769 | A METHOD FOR ISOLATING A MICROORGANISM | Non-Final OA | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED |
| 18561070 | METHOD OF PRODUCING BIOLOGICAL MATERIAL | Final Rejection | NTT, Inc. |
| 17280882 | Multi-Use Fermentation Products Obtained Through Production of Sophorolipids | Non-Final OA | Locus Solutions IPCo, LLC |
| 18560883 | ENGINEERED CELLS, ENZYMES, AND METHODS FOR PRODUCING CANNABINOIDS | Non-Final OA | Cellibre, Inc. |
| 14124535 | Spray-Dried Lactobacillus Stems/Cells and the Use of Same Against Helicobacter Pylori | Final Rejection | NOVOZYMES A/S |
| 18689550 | PREPARATION METHOD OF ECHINOCANDIN NUCLEUS | Non-Final OA | BIOCON LIMITED |
| 17639729 | Production of Sialylated Oligosaccharides in Bacillus Cells | Non-Final OA | Chr. Hansen A/S |
| 18560260 | ENZYMES, HOST CELLS, AND METHODS FOR PRODUCTION OF ROTUNDONE AND OTHER TERPENOIDS | Non-Final OA | MANUS BIO INC. |
| 18315169 | PROCESS FOR THE RECOVERY OF MICROALGAE USING MAGNETIC NANOPARTICLES OF BACTERIAL ORIGIN | Non-Final OA | UNIVERSIDADE FEDERAL DO RIO DE JANEIRO |
| 18284708 | METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE AND ENZYME USED FOR THE SAME | Non-Final OA | MicroBiopharm Japan Co., Ltd. |
| 17916414 | A METHOD OF DIAGNOSING AND/OR PROGNOSING PREECLAMPSIA | Final Rejection | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN |
| 16816009 | COMPOSITIONS, KITS, AND METHODS FOR DETECTING AUTOANTIBODIES | Final Rejection | Quidel Corporation |
| 17800728 | Biomarker for Predicting Prognosis of Radiotherapy for Lung Cancer | Final Rejection | Korea Institute of Radiological & Medical Sciences |
| 17920142 | METHOD AND DEVICE FOR ASSESSING A STATUS OF A WOUND OF A PATIENT | Non-Final OA | PAUL HARTMANN AG |
| 17907162 | NON INVASIVE METHODS FOR DIAGNOSING LIVER FIBROSIS | Final Rejection | King's College Hospital NHS Foundation Trust |
| 17608255 | RESPIRATORY INFECTION DETECTION AND CLASSIFICATION | Non-Final OA | AROCELL AB |
| 17314502 | METHOD, DEVICE, AND KIT FOR POPULATION SCREENING FOR CANCER, CANCER RECURRENCE AND PRECANCEROUS CONDITIONS IN SYMPTOM FREE INDIVIDUALS | Non-Final OA | CANCER PREVENTION, LLC |
| 17276142 | METHOD FOR CULTIVATING A MICROORGANISM OF INTEREST AND ASSOCIATED FACILITY | Final Rejection | KYANOS BIOTECHNOLOGIES |
| 16965324 | PLANT MICROBIAL PREPARATIONS, COMPOSITIONS AND FORMULATIONS COMPRISING SAME AND USES THEREOF | Non-Final OA | Lavie Bio Ltd |
| 16614321 | MINERAL BENEFICIATION METHOD USING BIOREAGENT EXTRACTED FROM GRAM POSITIVE BACTERIA | Final Rejection | ASSOCIAÇÃO INSTITUTO TECNOLÓGICO VALE – ITV |
| 15766558 | PROBIOTIC FORMULATION | Final Rejection | Bifodan A/S |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy